Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1994 | 03-1994 | 12-1993 | 09-1993 | 06-1993 | |
| Sales | 4,376 | 5,096 | 4,787 | 4,122 | 5,114 |
| Cost of Goods | 3,071 | 3,471 | 5,266 | 2,636 | 3,449 |
| Gross Profit | 643 | 1,625 | 2,925 | 1,485 | 1,666 |
| Operating Expenses | 4,103 | 3,924 | 5,976 | 4,794 | 4,988 |
| Operating Income | -2,727 | -1,828 | -6,189 | -2,672 | -2,874 |
| Interest Expense | 71 | 70 | 74 | 75 | 76 |
| Other Income | 77 | 65 | 3,491 | 205 | 175 |
| Pre-tax Income | -2,722 | -1,834 | -2,772 | -2,542 | -2,775 |
| Income Tax | 10 | 16 | 3 | 4 | 13 |
| Net Income Continuous | -2,732 | -1,849 | -3,047 | -2,546 | -2,788 |
| Net Income | $-2,732 | $-1,849 | $-3,047 | $-2,546 | $-2,788 |
| EPS Basic Total Ops | -14.40 | -10.40 | -17.60 | -15.20 | -16.80 |
| EPS Basic Continuous Ops | -14.70 | -10.65 | -17.86 | -15.01 | -16.59 |
| EPS Diluted Total Ops | -14.40 | -10.40 | -17.60 | -15.20 | -16.80 |
| EPS Diluted Continuous Ops | -14.70 | -10.65 | -17.86 | -15.01 | -16.59 |
| EBITDA(a) | $-2,727 | $-1,828 | $-6,189 | $-2,672 | $-2,874 |